LGF
ABBV icon

LGT Group Foundation’s AbbVie ABBV Stock Holding History

LGT Group Foundation’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111M Buy
441,958
+28,307
+7% +$6.09M 1.26% 19
2026
Q1 		$90M Buy
413,651
+89,567
+28% +$19.9M 1.1% 24
2025
Q4 		$74.5M Buy
324,084
+4,728
+1% +$1.08M 0.81% 31
2025
Q3 		$78M Buy
319,356
+75,622
+31% +$15.4M 0.89% 25
2025
Q2 		$45.2M Buy
243,734
+14,409
+6% +$2.68M 0.57% 41
2025
Q1 		$48M Buy
229,325
+82,619
+56% +$16.1M 0.66% 36
2024
Q4 		$26.1M Buy
146,706
+11,493
+8% +$2.11M 0.4% 52
2024
Q3 		$26.6M Buy
135,213
+54,759
+68% +$10.2M 0.44% 48
2024
Q2 		$13.8M Buy
80,454
+70,132
+679% +$11.6M 0.22% 74
2024
Q1 		$1.88M Sell
10,322
-1,943
-16% -$335K 0.04% 171
2023
Q4 		$1.9M Sell
12,265
-2,688
-18% -$392K 0.04% 181
2023
Q3 		$2.22M Buy
14,953
+1,709
+13% +$251K 0.05% 173
2023
Q2 		$1.78M Buy
13,244
+795
+6% +$117K 0.04% 198
2023
Q1 		$1.98M Sell
12,449
-2,384
-16% -$364K 0.06% 194
2022
Q4 		$2.4M Sell
14,833
-12,727
-46% -$1.95M 0.07% 180
2022
Q3 		$3.7M Sell
27,560
-2,289
-8% -$328K 0.14% 125
2022
Q2 		$4.57M Sell
29,849
-1,889
-6% -$289K 0.14% 125
2022
Q1 		$5.16M Sell
31,738
-35,056
-52% -$5.09M 0.12% 138
2021
Q4 		$9.04M Buy
+66,794
New +$7.89M 0.23% 97

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LGT Group Foundation's ABBV Position: Q2 2026 in Review

LGT Group Foundation increased its AbbVie (ABBV) stake by 6.8% in Q2 2026, buying an estimated $6.09M and bringing the position to 441,958 shares worth $111M. The position accounts for 1.26% of the portfolio, ranked #19.

LGT Group Foundation first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • LGT Group Foundation held 441,958 shares of AbbVie worth $111M as of Q2 2026.
  • LGT Group Foundation bought 28,307 AbbVie shares in Q2 2026, an estimated $6.09M.
  • AbbVie made up 1.26% of LGT Group Foundation's portfolio in Q2 2026, its #19 holding.
  • LGT Group Foundation first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.